Slingshot members are tracking this event:
Data for Phase 2 MONARCH 1 Trial of Abemaciclib Expected mid-2016
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Jun 03, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Monarch 1 Study, Phase 2 Trial, Abemaciclib, Single-agent, Non-small Cell Lung Cancer